WO2024062344 - SOLID STATE FORMS OF MESDOPETAM AND SALTS THEROF
National phase entry is expected:
Publication Number
WO/2024/062344
Publication Date
28.03.2024
International Application No.
PCT/IB2023/059085
International Filing Date
13.09.2023
Title **
[English]
SOLID STATE FORMS OF MESDOPETAM AND SALTS THEROF
[French]
FORMES À L'ÉTAT SOLIDE DE MESDOPÉTAM ET LEURS SELS
Applicants **
ASSIA CHEMICAL INDUSTRIES LTD.
124 Dvora HaNevi'a St.
6944020 Tel Aviv, IL
Inventors
TRAVANČIĆ, Valentina
Pavlenski put 5/O
10000 Zagreb, HR
KORDIĆ, Lorena
Barbat 286
51280 Rab, HR
CERIĆ, Helena
Bribirska 5
10000 Zagreb, HR
Priority Data
63/408,516
21.09.2022
US
63/422,047
03.11.2022
US
63/422,056
03.11.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1485 | |
| EPO | Filing, Examination | 6652 | |
| Japan | Filing | 593 | |
| South Korea | Filing | 641 | |
| USA | Filing, Examination | 5635 |
Total: 15006 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present disclosure encompasses Mesdopetam salts, solid state forms of Mesdopetam and salts thereof, in embodiments processes for preparation thereof and pharmaceutical compositions thereof.[French]
La présente divulgation concerne des sels de mesdopétam, des formes à l'état solide de mesdopétam et des sels de ceux-ci, dans des modes de réalisation des procédés de préparation de ceux-ci et des compositions pharmaceutiques de ceux-ci.